ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Pharma service firms target California

by Jean-François Tremblay
August 21, 2016 | APPEARED IN VOLUME 94, ISSUE 33

Selvita, a Polish drug discovery service firm, and Shanghai SynTheAll Pharmaceuticals Co. (STA), the small-molecule manufacturing subsidiary of China’s WuXi AppTec, are both increasing their presence in California. Selvita will provide the University of California, San Francisco, with synthesis, structure determination, and purity analysis services for small molecules that target neurodegenerative diseases. Separately, STA is opening a lab in San Diego that will provide process R&D and manufacturing services for molecules in early clinical studies. STA’s commercial facilities are in the Chinese cities of Shanghai and Changzhou.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment